Two main findings emerge from this study: first, the CMKLR1 receptor expression was associated with obesity and its features, and second, its ligand chemerin was associated not only with obesity, but also with metabolic dysfunction such as dyslipidemia and IR. Here, RARRES2 is linked to metabolic syndrome.